Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
Intracellular antibodies can inhibit disease-relevant protein interactions, but inefficient cellular uptake limits their utility. Using a RAS-targeting intracellular antibody as a screening tool, the authors here identify small molecules that inhibit RAS-effector interactions and readily penetrate c...
Guardado en:
Autores principales: | Camilo E. Quevedo, Abimael Cruz-Migoni, Nicolas Bery, Ami Miller, Tomoyuki Tanaka, Donna Petch, Carole J. R. Bataille, Lydia Y. W. Lee, Phillip S. Fallon, Hanna Tulmin, Matthias T. Ehebauer, Narcis Fernandez-Fuentes, Angela J. Russell, Stephen B. Carr, Simon E. V. Phillips, Terence H. Rabbitts |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67c80be1d0a14b3aa0feecf6b7e3b832 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pan RAS-binding compounds selected from a chemical library by inhibiting interaction between RAS and a reduced affinity intracellular antibody
por: Tomoyuki Tanaka, et al.
Publicado: (2021) -
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
por: Nicolas Bery, et al.
Publicado: (2020) -
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
por: Sandrine Guillard, et al.
Publicado: (2017) -
Predicted ‘wiring landscape’ of Ras-effector interactions in 29 human tissues
por: Simona Catozzi, et al.
Publicado: (2021) -
DNase γ is the effector endonuclease for internucleosomal DNA fragmentation in necrosis.
por: Ryushin Mizuta, et al.
Publicado: (2013)